Combining insulin and semaglutide for memory in MCI with metabolic syndrome
Treatments studied
Part of Brain & nervous system, Hormones & metabolism, Mental health clinical trials.
This study tests if a combination of insulin and semaglutide (a diabetes drug) can improve memory and thinking in people with mild cognitive impairment (MCI) who also have metabolic syndrome (a cluster of health issues like large waist, high blood sugar, and high blood pressure). It aims to see if treating blood sugar problems helps protect the brain.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with mild cognitive impairment (MCI) based on specific memory tests.
- You have metabolic syndrome, which means a large waist, high blood sugar, and either abnormal cholesterol or high blood pressure.
- You can speak and understand Hebrew fluently.
- You have a friend or family member who can act as a study partner and come to visits with you.
- You do not have diabetes (type 1 or type 2).
- You are not taking medications like corticosteroids or Ozempic that affect blood sugar.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether an oral diabetes medicine called semaglutide can help people with mild-to-moderate Alzheimer's disease. It may work by reducing inflammation or protecting brain cells, and researchers want to see if it slows memory loss.
This study tests if a new type of diabetes drug that targets two natural hormones can help people with type 2 diabetes who also have early memory problems. If you have type 2 diabetes and mild cognitive impairment or mild dementia, this trial may offer a potential treatment option.
This trial tests whether semaglutide, a drug used for diabetes and weight loss, can improve heart-related health in people with schizophrenia who also have metabolic syndrome (a cluster of conditions like high blood pressure, high blood sugar, and excess belly fat). If it works, it could lower the risk of heart disease and stroke.
This trial tests a new approach to treating Alzheimer's disease by improving both treatment and monitoring. It may help people with mild to moderate Alzheimer's who have specific brain changes seen on scans and in spinal fluid tests.
This trial tests whether semaglutide changes blood flow in the brain and the brain’s “barrier” (how well the brain is protected) in people with type 2 diabetes. It may help researchers understand brain-related effects of diabetes treatment using scans and blood tests.
This study tests whether two drugs—IL-2 (an immune-boosting medication) and semaglutide (a diabetes drug that may help brain function)—can slow memory loss in people with Alzheimer's disease. Researchers believe these drugs together might help reduce brain inflammation and protect memory.
Hear when a new Mild Cognitive Impairment trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.